nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—Fosphenytoin—epilepsy syndrome	0.208	0.446	CrCtD
Phenylbutazone—Phenytoin—epilepsy syndrome	0.143	0.305	CrCtD
Phenylbutazone—Clobazam—epilepsy syndrome	0.116	0.249	CrCtD
Phenylbutazone—PTGS2—epilepsy syndrome	0.0535	1	CbGaD
Phenylbutazone—Fosphenytoin—Phenytoin—epilepsy syndrome	0.0251	0.0901	CrCrCtD
Phenylbutazone—Doxapram—Fosphenytoin—epilepsy syndrome	0.0189	0.0678	CrCrCtD
Phenylbutazone—Phenytoin—Fosphenytoin—epilepsy syndrome	0.0172	0.0617	CrCrCtD
Phenylbutazone—Phenytoin—Primidone—epilepsy syndrome	0.0172	0.0617	CrCrCtD
Phenylbutazone—Protriptyline—Carbamazepine—epilepsy syndrome	0.0141	0.0507	CrCrCtD
Phenylbutazone—Doxapram—Phenytoin—epilepsy syndrome	0.013	0.0465	CrCrCtD
Phenylbutazone—Phenytoin—Phenobarbital—epilepsy syndrome	0.0127	0.0455	CrCrCtD
Phenylbutazone—Phenindione—Fosphenytoin—epilepsy syndrome	0.0121	0.0434	CrCrCtD
Phenylbutazone—Oxaprozin—Phenytoin—epilepsy syndrome	0.0118	0.0423	CrCrCtD
Phenylbutazone—PTGS1—Diazepam—epilepsy syndrome	0.0117	0.0684	CbGbCtD
Phenylbutazone—SLC22A8—Valproic Acid—epilepsy syndrome	0.0116	0.0679	CbGbCtD
Phenylbutazone—Oxaprozin—Carbamazepine—epilepsy syndrome	0.0109	0.0391	CrCrCtD
Phenylbutazone—Phenytoin—Carbamazepine—epilepsy syndrome	0.0109	0.0391	CrCrCtD
Phenylbutazone—SLC22A6—Acetazolamide—epilepsy syndrome	0.0108	0.0633	CbGbCtD
Phenylbutazone—Phenprocoumon—Phenytoin—epilepsy syndrome	0.0104	0.0374	CrCrCtD
Phenylbutazone—Modafinil—Fosphenytoin—epilepsy syndrome	0.0101	0.0363	CrCrCtD
Phenylbutazone—PTGS1—Valproic Acid—epilepsy syndrome	0.00923	0.054	CbGbCtD
Phenylbutazone—CYP2C9—Trimethadione—epilepsy syndrome	0.00921	0.0538	CbGbCtD
Phenylbutazone—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00866	0.0506	CbGbCtD
Phenylbutazone—Phenindione—Phenytoin—epilepsy syndrome	0.00829	0.0297	CrCrCtD
Phenylbutazone—SLC22A6—Valproic Acid—epilepsy syndrome	0.00809	0.0473	CbGbCtD
Phenylbutazone—Phenindione—Carbamazepine—epilepsy syndrome	0.00765	0.0274	CrCrCtD
Phenylbutazone—Phenindione—Oxcarbazepine—epilepsy syndrome	0.00705	0.0253	CrCrCtD
Phenylbutazone—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.00705	0.0253	CrCrCtD
Phenylbutazone—Modafinil—Phenytoin—epilepsy syndrome	0.00694	0.0249	CrCrCtD
Phenylbutazone—Phenindione—Clobazam—epilepsy syndrome	0.00676	0.0242	CrCrCtD
Phenylbutazone—Clobazam—Midazolam—epilepsy syndrome	0.00667	0.0239	CrCrCtD
Phenylbutazone—Clobazam—Oxcarbazepine—epilepsy syndrome	0.00667	0.0239	CrCrCtD
Phenylbutazone—Modafinil—Carbamazepine—epilepsy syndrome	0.0064	0.0229	CrCrCtD
Phenylbutazone—CYP2C9—Carbamazepine—epilepsy syndrome	0.00622	0.0364	CbGbCtD
Phenylbutazone—Clobazam—Diazepam—epilepsy syndrome	0.00595	0.0213	CrCrCtD
Phenylbutazone—Modafinil—Oxcarbazepine—epilepsy syndrome	0.0059	0.0211	CrCrCtD
Phenylbutazone—CYP2C9—Primidone—epilepsy syndrome	0.00581	0.0339	CbGbCtD
Phenylbutazone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00576	0.0337	CbGbCtD
Phenylbutazone—CYP2C9—Phenytoin—epilepsy syndrome	0.00558	0.0326	CbGbCtD
Phenylbutazone—CYP3A4—Trimethadione—epilepsy syndrome	0.00535	0.0313	CbGbCtD
Phenylbutazone—CYP3A4—Felbamate—epilepsy syndrome	0.00535	0.0313	CbGbCtD
Phenylbutazone—Benzphetamine—Phenytoin—epilepsy syndrome	0.00521	0.0187	CrCrCtD
Phenylbutazone—CYP2C9—Propofol—epilepsy syndrome	0.0052	0.0304	CbGbCtD
Phenylbutazone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00503	0.0294	CbGbCtD
Phenylbutazone—CYP2C9—Phenobarbital—epilepsy syndrome	0.00497	0.0291	CbGbCtD
Phenylbutazone—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.00483	0.0173	CrCrCtD
Phenylbutazone—CYP2C9—Diazepam—epilepsy syndrome	0.00471	0.0275	CbGbCtD
Phenylbutazone—Diphenhydramine—Phenytoin—epilepsy syndrome	0.00463	0.0166	CrCrCtD
Phenylbutazone—CYP3A4—Clonazepam—epilepsy syndrome	0.00455	0.0266	CbGbCtD
Phenylbutazone—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.00446	0.016	CrCrCtD
Phenylbutazone—CYP3A4—Clobazam—epilepsy syndrome	0.00436	0.0255	CbGbCtD
Phenylbutazone—CYP2C9—Valproic Acid—epilepsy syndrome	0.00372	0.0217	CbGbCtD
Phenylbutazone—CYP3A4—Rufinamide—epilepsy syndrome	0.00371	0.0217	CbGbCtD
Phenylbutazone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00362	0.0211	CbGbCtD
Phenylbutazone—CYP3A4—Primidone—epilepsy syndrome	0.00338	0.0197	CbGbCtD
Phenylbutazone—CYP3A4—Phenytoin—epilepsy syndrome	0.00324	0.019	CbGbCtD
Phenylbutazone—CYP3A4—Propofol—epilepsy syndrome	0.00302	0.0177	CbGbCtD
Phenylbutazone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00289	0.0169	CbGbCtD
Phenylbutazone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00289	0.0169	CbGbCtD
Phenylbutazone—CYP3A4—Midazolam—epilepsy syndrome	0.00285	0.0167	CbGbCtD
Phenylbutazone—CYP3A4—Diazepam—epilepsy syndrome	0.00274	0.016	CbGbCtD
Phenylbutazone—CYP3A4—Zonisamide—epilepsy syndrome	0.00267	0.0156	CbGbCtD
Phenylbutazone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00216	0.0126	CbGbCtD
Phenylbutazone—CYP3A4—Topiramate—epilepsy syndrome	0.00195	0.0114	CbGbCtD
Phenylbutazone—Doxapram—KCNK3—epilepsy syndrome	0.000357	0.154	CrCbGaD
Phenylbutazone—Doxapram—KCNK9—epilepsy syndrome	0.000357	0.154	CrCbGaD
Phenylbutazone—Clobazam—SLC6A1—epilepsy syndrome	0.00013	0.0562	CrCbGaD
Phenylbutazone—Phenytoin—SCN8A—epilepsy syndrome	0.000108	0.0468	CrCbGaD
Phenylbutazone—Phenytoin—SCN9A—epilepsy syndrome	8.77e-05	0.0379	CrCbGaD
Phenylbutazone—Phenytoin—SCN3A—epilepsy syndrome	8.39e-05	0.0362	CrCbGaD
Phenylbutazone—Phenytoin—SCN4A—epilepsy syndrome	8.06e-05	0.0348	CrCbGaD
Phenylbutazone—Clobazam—GABRG2—epilepsy syndrome	6.25e-05	0.027	CrCbGaD
Phenylbutazone—Trimethaphan—BCHE—epilepsy syndrome	5.91e-05	0.0255	CrCbGaD
Phenylbutazone—Phenytoin—SCN1A—epilepsy syndrome	5.89e-05	0.0254	CrCbGaD
Phenylbutazone—Sulfinpyrazone—ABCC2—epilepsy syndrome	5.38e-05	0.0232	CrCbGaD
Phenylbutazone—Phenytoin—SCN2A—epilepsy syndrome	5.19e-05	0.0224	CrCbGaD
Phenylbutazone—Dextropropoxyphene—OPRD1—epilepsy syndrome	5.16e-05	0.0223	CrCbGaD
Phenylbutazone—Fentanyl—OPRD1—epilepsy syndrome	5.11e-05	0.022	CrCbGaD
Phenylbutazone—Clobazam—GABRB2—epilepsy syndrome	4.4e-05	0.019	CrCbGaD
Phenylbutazone—Clobazam—GABRA1—epilepsy syndrome	4.32e-05	0.0186	CrCbGaD
Phenylbutazone—Protriptyline—SLC6A4—epilepsy syndrome	4.32e-05	0.0186	CrCbGaD
Phenylbutazone—Fosphenytoin—CYP2C19—epilepsy syndrome	4.19e-05	0.0181	CrCbGaD
Phenylbutazone—Dextropropoxyphene—OPRM1—epilepsy syndrome	3.95e-05	0.0171	CrCbGaD
Phenylbutazone—Fentanyl—OPRM1—epilepsy syndrome	3.91e-05	0.0169	CrCbGaD
Phenylbutazone—Methadone—OPRD1—epilepsy syndrome	3.5e-05	0.0151	CrCbGaD
Phenylbutazone—Protriptyline—CYP2D6—epilepsy syndrome	3.03e-05	0.0131	CrCbGaD
Phenylbutazone—Methadone—OPRM1—epilepsy syndrome	2.68e-05	0.0116	CrCbGaD
Phenylbutazone—Phenytoin—ABCC2—epilepsy syndrome	2.66e-05	0.0115	CrCbGaD
Phenylbutazone—Oxaprozin—PTGS2—epilepsy syndrome	2.51e-05	0.0108	CrCbGaD
Phenylbutazone—Benzphetamine—ADRA2A—epilepsy syndrome	2.5e-05	0.0108	CrCbGaD
Phenylbutazone—Phenoxybenzamine—ADRA2A—epilepsy syndrome	2.39e-05	0.0103	CrCbGaD
Phenylbutazone—Diphenhydramine—CHRM2—epilepsy syndrome	2.35e-05	0.0101	CrCbGaD
Phenylbutazone—Fosphenytoin—ALB—epilepsy syndrome	2.32e-05	0.01	CrCbGaD
Phenylbutazone—Protriptyline—ABCB1—epilepsy syndrome	2.17e-05	0.00935	CrCbGaD
Phenylbutazone—Modafinil—CYP2C19—epilepsy syndrome	2.09e-05	0.00901	CrCbGaD
Phenylbutazone—Clobazam—CYP2C19—epilepsy syndrome	2.03e-05	0.00876	CrCbGaD
Phenylbutazone—Sulfinpyrazone—ABCB1—epilepsy syndrome	1.98e-05	0.00855	CrCbGaD
Phenylbutazone—Phenytoin—CYP2C19—epilepsy syndrome	1.85e-05	0.00799	CrCbGaD
Phenylbutazone—Phenprocoumon—ALB—epilepsy syndrome	1.59e-05	0.00688	CrCbGaD
Phenylbutazone—Dextropropoxyphene—CYP2D6—epilepsy syndrome	1.53e-05	0.0066	CrCbGaD
Phenylbutazone—Diphenhydramine—CYP2C19—epilepsy syndrome	1.45e-05	0.00626	CrCbGaD
Phenylbutazone—Methadone—CYP2C19—epilepsy syndrome	1.4e-05	0.00604	CrCbGaD
Phenylbutazone—Fentanyl—ABCB1—epilepsy syndrome	1.08e-05	0.00466	CrCbGaD
Phenylbutazone—Diphenhydramine—CYP2D6—epilepsy syndrome	1.07e-05	0.00464	CrCbGaD
Phenylbutazone—Clobazam—ABCB1—epilepsy syndrome	1.07e-05	0.00464	CrCbGaD
Phenylbutazone—Methadone—CYP2D6—epilepsy syndrome	1.04e-05	0.00448	CrCbGaD
Phenylbutazone—Phenytoin—ALB—epilepsy syndrome	1.03e-05	0.00443	CrCbGaD
Phenylbutazone—Phenytoin—ABCB1—epilepsy syndrome	9.8e-06	0.00423	CrCbGaD
Phenylbutazone—Methadone—ABCB1—epilepsy syndrome	7.41e-06	0.0032	CrCbGaD
Phenylbutazone—PTGS2—Metabolism—ATIC—epilepsy syndrome	7.22e-06	0.000268	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NEU1—epilepsy syndrome	7.22e-06	0.000268	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—UPB1—epilepsy syndrome	7.22e-06	0.000268	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—APOE—epilepsy syndrome	7.21e-06	0.000267	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CACNA1A—epilepsy syndrome	7.19e-06	0.000267	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALDH7A1—epilepsy syndrome	7.19e-06	0.000267	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.19e-06	0.000267	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	7.18e-06	0.000266	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ST3GAL3—epilepsy syndrome	7.04e-06	0.000261	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	6.95e-06	0.000258	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CERS1—epilepsy syndrome	6.9e-06	0.000256	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	6.9e-06	0.000256	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	6.9e-06	0.000256	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ADK—epilepsy syndrome	6.9e-06	0.000256	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PDXK—epilepsy syndrome	6.9e-06	0.000256	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—FAR1—epilepsy syndrome	6.9e-06	0.000256	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ADSL—epilepsy syndrome	6.9e-06	0.000256	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	6.82e-06	0.000253	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GLUL—epilepsy syndrome	6.76e-06	0.000251	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GBE1—epilepsy syndrome	6.71e-06	0.000249	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	6.71e-06	0.000249	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ST3GAL3—epilepsy syndrome	6.67e-06	0.000247	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CACNA1D—epilepsy syndrome	6.64e-06	0.000246	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.56e-06	0.000243	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—FGF2—epilepsy syndrome	6.54e-06	0.000242	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	6.43e-06	0.000238	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ASAH1—epilepsy syndrome	6.31e-06	0.000234	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PNPO—epilepsy syndrome	6.31e-06	0.000234	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	6.31e-06	0.000234	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GAMT—epilepsy syndrome	6.31e-06	0.000234	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	6.31e-06	0.000234	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—TXNRD1—epilepsy syndrome	6.21e-06	0.00023	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—POMC—epilepsy syndrome	6.19e-06	0.00023	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—STXBP1—epilepsy syndrome	6.14e-06	0.000228	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AQP1—epilepsy syndrome	6.03e-06	0.000223	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	6.01e-06	0.000223	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CA13—epilepsy syndrome	6e-06	0.000223	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NT5E—epilepsy syndrome	5.98e-06	0.000222	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALAD—epilepsy syndrome	5.98e-06	0.000222	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MTOR—epilepsy syndrome	5.95e-06	0.000221	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTGS2—epilepsy syndrome	5.9e-06	0.000219	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CA4—epilepsy syndrome	5.87e-06	0.000218	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—QDPR—epilepsy syndrome	5.87e-06	0.000218	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	5.85e-06	0.000217	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	5.84e-06	0.000217	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.79e-06	0.000215	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	5.71e-06	0.000212	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	5.71e-06	0.000212	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ALB—epilepsy syndrome	5.64e-06	0.000209	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	5.59e-06	0.000207	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—COX3—epilepsy syndrome	5.52e-06	0.000205	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.48e-06	0.000203	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ADSL—epilepsy syndrome	5.47e-06	0.000203	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CHRM3—epilepsy syndrome	5.45e-06	0.000202	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	5.45e-06	0.000202	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GLUL—epilepsy syndrome	5.37e-06	0.000199	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	5.27e-06	0.000195	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	5.24e-06	0.000194	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PFKL—epilepsy syndrome	5.23e-06	0.000194	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	5.23e-06	0.000194	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	5.23e-06	0.000194	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	5.23e-06	0.000194	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	5.23e-06	0.000194	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	5.11e-06	0.00019	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	5.1e-06	0.000189	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	5.08e-06	0.000188	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.08e-06	0.000188	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.97e-06	0.000184	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—epilepsy syndrome	4.94e-06	0.000183	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	4.93e-06	0.000183	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EIF2AK2—epilepsy syndrome	4.86e-06	0.00018	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AQP1—epilepsy syndrome	4.78e-06	0.000177	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—UPB1—epilepsy syndrome	4.78e-06	0.000177	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ATIC—epilepsy syndrome	4.78e-06	0.000177	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NEU1—epilepsy syndrome	4.78e-06	0.000177	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SRC—epilepsy syndrome	4.77e-06	0.000177	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	4.6e-06	0.000171	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.6e-06	0.00017	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.58e-06	0.00017	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PDXK—epilepsy syndrome	4.55e-06	0.000169	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—FAR1—epilepsy syndrome	4.55e-06	0.000169	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	4.55e-06	0.000169	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ADK—epilepsy syndrome	4.55e-06	0.000169	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	4.55e-06	0.000169	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CERS1—epilepsy syndrome	4.55e-06	0.000169	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PPIA—epilepsy syndrome	4.49e-06	0.000167	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GBE1—epilepsy syndrome	4.45e-06	0.000165	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	4.45e-06	0.000165	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ABCG2—epilepsy syndrome	4.44e-06	0.000165	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.37e-06	0.000162	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	4.35e-06	0.000161	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	4.33e-06	0.000161	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CHRM3—epilepsy syndrome	4.33e-06	0.00016	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	4.33e-06	0.00016	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	4.3e-06	0.00016	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.27e-06	0.000158	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	4.18e-06	0.000155	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	4.16e-06	0.000154	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	4.16e-06	0.000154	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PNPO—epilepsy syndrome	4.16e-06	0.000154	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GAMT—epilepsy syndrome	4.16e-06	0.000154	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	4.07e-06	0.000151	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.03e-06	0.000149	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALAD—epilepsy syndrome	3.96e-06	0.000147	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NT5E—epilepsy syndrome	3.96e-06	0.000147	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.95e-06	0.000146	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.9e-06	0.000144	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	3.88e-06	0.000144	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CA4—epilepsy syndrome	3.87e-06	0.000143	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—QDPR—epilepsy syndrome	3.87e-06	0.000143	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	3.86e-06	0.000143	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	3.78e-06	0.00014	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	3.78e-06	0.00014	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	3.7e-06	0.000137	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	3.7e-06	0.000137	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—BCHE—epilepsy syndrome	3.68e-06	0.000137	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.64e-06	0.000135	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ADSL—epilepsy syndrome	3.62e-06	0.000134	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GLUL—epilepsy syndrome	3.55e-06	0.000132	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCG2—epilepsy syndrome	3.53e-06	0.000131	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	3.51e-06	0.00013	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	3.49e-06	0.000129	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PLCB1—epilepsy syndrome	3.47e-06	0.000129	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—TH—epilepsy syndrome	3.46e-06	0.000128	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.45e-06	0.000128	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.45e-06	0.000128	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.45e-06	0.000128	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.45e-06	0.000128	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.45e-06	0.000128	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	3.44e-06	0.000127	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	3.42e-06	0.000127	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.41e-06	0.000126	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.39e-06	0.000126	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SLC2A1—epilepsy syndrome	3.33e-06	0.000123	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—JUNB—epilepsy syndrome	3.3e-06	0.000123	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS1—epilepsy syndrome	3.28e-06	0.000122	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	3.26e-06	0.000121	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.26e-06	0.000121	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.17e-06	0.000117	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.15e-06	0.000117	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.15e-06	0.000117	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.15e-06	0.000117	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HBEGF—epilepsy syndrome	3.13e-06	0.000116	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.09e-06	0.000115	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	3.08e-06	0.000114	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT3—epilepsy syndrome	3.07e-06	0.000114	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.04e-06	0.000113	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.04e-06	0.000113	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ADAM10—epilepsy syndrome	3e-06	0.000111	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT1—epilepsy syndrome	2.96e-06	0.00011	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	2.93e-06	0.000109	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.93e-06	0.000109	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.93e-06	0.000109	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—BCHE—epilepsy syndrome	2.92e-06	0.000108	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HMOX1—epilepsy syndrome	2.89e-06	0.000107	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	2.87e-06	0.000106	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	2.87e-06	0.000106	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CAT—epilepsy syndrome	2.85e-06	0.000106	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDC42—epilepsy syndrome	2.8e-06	0.000104	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	2.79e-06	0.000103	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ABCB1—epilepsy syndrome	2.77e-06	0.000103	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PLCB1—epilepsy syndrome	2.76e-06	0.000102	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.76e-06	0.000102	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—TH—epilepsy syndrome	2.75e-06	0.000102	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.68e-06	9.95e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.67e-06	9.89e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.61e-06	9.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.61e-06	9.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.61e-06	9.69e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GPX1—epilepsy syndrome	2.58e-06	9.56e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HES1—epilepsy syndrome	2.57e-06	9.52e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FYN—epilepsy syndrome	2.5e-06	9.25e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.49e-06	9.25e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.49e-06	9.25e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—H2AFX—epilepsy syndrome	2.49e-06	9.22e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKT1—epilepsy syndrome	2.48e-06	9.2e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.44e-06	9.05e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—YWHAZ—epilepsy syndrome	2.4e-06	8.9e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.39e-06	8.86e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.34e-06	8.69e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.34e-06	8.66e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CCR5—epilepsy syndrome	2.31e-06	8.56e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.3e-06	8.53e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HMOX1—epilepsy syndrome	2.29e-06	8.5e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.28e-06	8.44e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CAT—epilepsy syndrome	2.26e-06	8.39e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.26e-06	8.39e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AGT—epilepsy syndrome	2.26e-06	8.38e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.25e-06	8.33e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOE—epilepsy syndrome	2.21e-06	8.21e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCB1—epilepsy syndrome	2.2e-06	8.16e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.15e-06	7.98e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TSC2—epilepsy syndrome	2.15e-06	7.96e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOE—epilepsy syndrome	2.1e-06	7.78e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.09e-06	7.75e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.05e-06	7.59e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GPX1—epilepsy syndrome	2.05e-06	7.59e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.04e-06	7.57e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6ST—epilepsy syndrome	1.97e-06	7.31e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS2—epilepsy syndrome	1.96e-06	7.25e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.94e-06	7.21e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.94e-06	7.18e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—POMC—epilepsy syndrome	1.9e-06	7.06e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.89e-06	7.01e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.89e-06	7.01e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.85e-06	6.85e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.83e-06	6.77e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—TH—epilepsy syndrome	1.82e-06	6.75e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AGT—epilepsy syndrome	1.79e-06	6.65e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.79e-06	6.64e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOE—epilepsy syndrome	1.76e-06	6.52e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALB—epilepsy syndrome	1.73e-06	6.43e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGF2—epilepsy syndrome	1.59e-06	5.91e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.54e-06	5.71e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.52e-06	5.63e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—epilepsy syndrome	1.52e-06	5.63e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—POMC—epilepsy syndrome	1.51e-06	5.6e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.5e-06	5.57e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.5e-06	5.56e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.49e-06	5.53e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.46e-06	5.41e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTOR—epilepsy syndrome	1.45e-06	5.38e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALB—epilepsy syndrome	1.38e-06	5.11e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.36e-06	5.03e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.35e-06	4.99e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.28e-06	4.75e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.28e-06	4.73e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.22e-06	4.52e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.2e-06	4.47e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TH—epilepsy syndrome	1.2e-06	4.45e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.19e-06	4.41e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.16e-06	4.32e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SRC—epilepsy syndrome	1.16e-06	4.31e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1e-06	3.71e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—POMC—epilepsy syndrome	1e-06	3.71e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CAT—epilepsy syndrome	9.88e-07	3.66e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	9.61e-07	3.56e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALB—epilepsy syndrome	9.12e-07	3.38e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	8.94e-07	3.31e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	7.98e-07	2.96e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.84e-07	2.91e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOE—epilepsy syndrome	7.68e-07	2.85e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKT1—epilepsy syndrome	7.63e-07	2.83e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT1—epilepsy syndrome	7.23e-07	2.68e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.6e-07	2.45e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKT1—epilepsy syndrome	6.06e-07	2.25e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.01e-07	2.23e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.26e-07	1.95e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.01e-07	1.49e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.64e-07	9.81e-06	CbGpPWpGaD
